Embosphere® PROstate Post Market Study

Completed

Conditions studied: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms

In brief

Prostatic artery embolization with Embosphere Microspheres is a relatively new procedure. The goal of this post market study is to evaluate long-term safety and effectiveness in a 'real world' setting.

Key facts

Study ID

NCT03527589

Run by

Merit Medical Systems, Inc.

People needed

499

Starts

2018-08-16

Expected to finish

2022-01-22

Last updated by the study team

2023-12-18

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patient has signed informed consent
• Patient age is 18 years or older at time of informed consent
• Patient will undergo prostatic artery embolization with Embosphere Microspheres for the treatment of symptomatic benign prostatic hyperplasia with lower urinary tract symptoms

You may not qualify if…

• Patient is unable or unwilling to provide follow-up information
• Patient is undergoing prostatic artery embolization for reasons that do not include symptomatic benign prostatic hyperplasia with lower urinary tract symptoms
• Any other reason the investigator deems cause for exclusion

Where it is running

• VA Long Beach Healthcare Systems — Long Beach, California, United States
• Ronald Reagan UCLA Medical Center — Los Angeles, California, United States
• University of California Los Angeles — Los Angeles, California, United States
• UC Irvine Health — Orange, California, United States
• Holy Cross Hospital — Fort Lauderdale, Florida, United States
• University of Miami- Miller School of Medicine — Miami, Florida, United States
• St. Louis University Hospital — St Louis, Missouri, United States
• Providence Sacred Heart — Spokane, Washington, United States
• Hôspital Européan Georges Pompidou HEGP — Paris, France
• Azienda Ospedaliera S. Croce e Carle Cuneo — Cuneo, Italy
• Ospedale Niguarda Ca' Granda — Milan, Italy
• Churchill Hospital — Headington, Oxford, United Kingdom
• Frimley Park Hospital — Camberley, Surrey, United Kingdom
• Royal Bournemouth and Christchurch Hospital — Bournemouth, United Kingdom
• Royal Berkshire Hospital — Reading, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.